<?xml version='1.0' encoding='utf-8'?>
<document id="24741184"><sentence text="A study of potential drug-drug interactions among hospitalized cardiac patients in a teaching hospital in Western Nepal." /><sentence text="Drug-drug interaction (DDI) is of major concern in patients with complex therapeutic regimens" /><sentence text=" The involvement of cardiovascular medicines in drug interaction is even higher" /><sentence text=" However, reports of DDI between these groups of drugs are few" /><sentence text=" The study aims to identify the potential DDI among hospitalized cardiac patients" /><sentence text=" Furthermore, we assessed the possible risk factors associated with these interactions" /><sentence text="" /><sentence text="The Type of study prospective observational study was conducted from May 2012 to August 2012 among hospitalized cardiac patients" /><sentence text=" Cardiac patients who were taking at least two drugs and who had a hospital stay of at least 24 h were enrolled" /><sentence text=" The medications of the patients were analyzed for possible interactions using the standard drug interaction database - Micromedex -2 (Thomson Reuters) Ã— 2" /><sentence text="0" /><sentence text="" /><sentence text="From a total of 150 enrolled patients, at least one interacting drug combination was identified among 32 patients" /><sentence text=" The incidence of potential DDI was 21" /><sentence text="3%" /><sentence text=" A total of 48 potentially hazardous drug interactions were identified" /><sentence text=" Atorvastatin/azithromycin (10"><entity charOffset="1-13" id="DDI-PubMed.24741184.s17.e0" text="Atorvastatin" /><entity charOffset="14-26" id="DDI-PubMed.24741184.s17.e1" text="azithromycin" /><pair ddi="false" e1="DDI-PubMed.24741184.s17.e0" e2="DDI-PubMed.24741184.s17.e0" /><pair ddi="false" e1="DDI-PubMed.24741184.s17.e0" e2="DDI-PubMed.24741184.s17.e1" /></sentence><sentence text="4%), enalapril/metformin (10"><entity charOffset="5-14" id="DDI-PubMed.24741184.s18.e0" text="enalapril" /><entity charOffset="15-24" id="DDI-PubMed.24741184.s18.e1" text="metformin" /><pair ddi="false" e1="DDI-PubMed.24741184.s18.e0" e2="DDI-PubMed.24741184.s18.e0" /><pair ddi="false" e1="DDI-PubMed.24741184.s18.e0" e2="DDI-PubMed.24741184.s18.e1" /></sentence><sentence text="4%), enalapril/potassium chloride (10"><entity charOffset="5-14" id="DDI-PubMed.24741184.s19.e0" text="enalapril" /><entity charOffset="15-33" id="DDI-PubMed.24741184.s19.e1" text="potassium chloride" /><pair ddi="false" e1="DDI-PubMed.24741184.s19.e0" e2="DDI-PubMed.24741184.s19.e0" /><pair ddi="false" e1="DDI-PubMed.24741184.s19.e0" e2="DDI-PubMed.24741184.s19.e1" /></sentence><sentence text="4%), atorvastatin/clarithromycin (8"><entity charOffset="5-17" id="DDI-PubMed.24741184.s20.e0" text="atorvastatin" /><entity charOffset="18-32" id="DDI-PubMed.24741184.s20.e1" text="clarithromycin" /><pair ddi="false" e1="DDI-PubMed.24741184.s20.e0" e2="DDI-PubMed.24741184.s20.e0" /><pair ddi="false" e1="DDI-PubMed.24741184.s20.e0" e2="DDI-PubMed.24741184.s20.e1" /></sentence><sentence text="3%) and furosemide/gentamicin (6"><entity charOffset="8-18" id="DDI-PubMed.24741184.s21.e0" text="furosemide" /><entity charOffset="19-29" id="DDI-PubMed.24741184.s21.e1" text="gentamicin" /><pair ddi="false" e1="DDI-PubMed.24741184.s21.e0" e2="DDI-PubMed.24741184.s21.e0" /><pair ddi="false" e1="DDI-PubMed.24741184.s21.e0" e2="DDI-PubMed.24741184.s21.e1" /></sentence><sentence text="3%) were the most common interacting pairs" /><sentence text=" Drugs most commonly involved were atorvastatin, enalapril, digoxin, furosemide, clopidogrel and warfarin"><entity charOffset="35-47" id="DDI-PubMed.24741184.s23.e0" text="atorvastatin" /><entity charOffset="49-58" id="DDI-PubMed.24741184.s23.e1" text="enalapril" /><entity charOffset="60-67" id="DDI-PubMed.24741184.s23.e2" text="digoxin" /><entity charOffset="69-79" id="DDI-PubMed.24741184.s23.e3" text="furosemide" /><entity charOffset="81-92" id="DDI-PubMed.24741184.s23.e4" text="clopidogrel" /><entity charOffset="97-105" id="DDI-PubMed.24741184.s23.e5" text="warfarin" /><pair ddi="false" e1="DDI-PubMed.24741184.s23.e0" e2="DDI-PubMed.24741184.s23.e0" /><pair ddi="false" e1="DDI-PubMed.24741184.s23.e0" e2="DDI-PubMed.24741184.s23.e1" /><pair ddi="false" e1="DDI-PubMed.24741184.s23.e0" e2="DDI-PubMed.24741184.s23.e2" /><pair ddi="false" e1="DDI-PubMed.24741184.s23.e0" e2="DDI-PubMed.24741184.s23.e3" /><pair ddi="false" e1="DDI-PubMed.24741184.s23.e0" e2="DDI-PubMed.24741184.s23.e4" /><pair ddi="false" e1="DDI-PubMed.24741184.s23.e0" e2="DDI-PubMed.24741184.s23.e5" /><pair ddi="false" e1="DDI-PubMed.24741184.s23.e1" e2="DDI-PubMed.24741184.s23.e1" /><pair ddi="false" e1="DDI-PubMed.24741184.s23.e1" e2="DDI-PubMed.24741184.s23.e2" /><pair ddi="false" e1="DDI-PubMed.24741184.s23.e1" e2="DDI-PubMed.24741184.s23.e3" /><pair ddi="false" e1="DDI-PubMed.24741184.s23.e1" e2="DDI-PubMed.24741184.s23.e4" /><pair ddi="false" e1="DDI-PubMed.24741184.s23.e1" e2="DDI-PubMed.24741184.s23.e5" /><pair ddi="false" e1="DDI-PubMed.24741184.s23.e2" e2="DDI-PubMed.24741184.s23.e2" /><pair ddi="false" e1="DDI-PubMed.24741184.s23.e2" e2="DDI-PubMed.24741184.s23.e3" /><pair ddi="false" e1="DDI-PubMed.24741184.s23.e2" e2="DDI-PubMed.24741184.s23.e4" /><pair ddi="false" e1="DDI-PubMed.24741184.s23.e2" e2="DDI-PubMed.24741184.s23.e5" /><pair ddi="false" e1="DDI-PubMed.24741184.s23.e3" e2="DDI-PubMed.24741184.s23.e3" /><pair ddi="false" e1="DDI-PubMed.24741184.s23.e3" e2="DDI-PubMed.24741184.s23.e4" /><pair ddi="false" e1="DDI-PubMed.24741184.s23.e3" e2="DDI-PubMed.24741184.s23.e5" /><pair ddi="false" e1="DDI-PubMed.24741184.s23.e4" e2="DDI-PubMed.24741184.s23.e4" /><pair ddi="false" e1="DDI-PubMed.24741184.s23.e4" e2="DDI-PubMed.24741184.s23.e5" /></sentence><sentence text=" Majority of interactions were of moderate severity (62" /><sentence text="5%) and pharmacokinetic (58" /><sentence text="3%) in nature" /><sentence text=" Increased number of medicines, prolonged hospital stays and comorbid conditions were the risk factors found associated with the potential DDI" /><sentence text="" /><sentence text="This study highlighted the need of intense monitoring of patients who have identified risk factors to help detect and prevent them from serious health hazards associated with drug interactions" /><sentence text="" /></document>